Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima

Journal of Antibiotics

Volumn 52, Issue 6, 1999, Pages 531-535

  Nara, Futoshi ^a   Tanaka, Masahiro ^a   Masuda Inoue, Seiko ^a   Yamasato, Yoko ^a   Doi Yoshioka, Hiromi ^a   Suzuki Konagai, Keiko ^a   Kumakura, Seiichiro ^a   Ogita, Takeshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CARRAGEENAN; ENZYME INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYSOSOME ENZYME; PROSTAGLANDIN E2; SCYPHOSTATIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; HUMAN; HUMAN CELL; MALE; MONOCYTE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT;

EID: 0032866198     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.531     Document Type: Article

References (19)

1. TOMINAGA, K.; T. KIRIKAE & M. NAKANO: Lipopolysaccharide (LPS)-induced IL-6 production by embryonic fibroblasts isolated and cloned from LPS-responsive and LPS-hyporesponsive mice. Molecular Immunology 34: 1147-1156, 1997
2. HAIMOVITZ-FRIEDMAN, A.; C. CORDON-CARDO, S. BAYOUMY, M. GARZOTTO, M. MCLOUGHLIN, R. GALLILY, C. K. EDWARDS III, E. H. SCHUCHMAN, Z. FUKS & R. KOLESNICK: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186: 1831-1841, 1997
3. PFAU, J. C.; E. B. WALKER & G. L. CARD: A comparison of the effects of lipopolysaccharide and ceramide on arachidonic acid metabolism in THP-1 monocytic cells. Cellular Immunology 186: 147-153, 1998
4. PAHAN, K.; F. G. SHEIKH, M. KHAN, A. M. S. NAMBOODIRI & I. SINGH: Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 273: 2591-2600, 1998
5. HANNUN, Y. A.: Sphingolipid-mediated signal transduction. Mol. Bio. Intel. Unit, Springer 19-34, 1997
6. MATHIAS, S.; L. A. PENA & R. N. KOLESNICK: Signal transduction of stress via ceramide. Biochem. J. 335: 465-480, 1998
7. PUSHKAREVA, M.; L. M. OBEIDO & Y. A. HANNUN: Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol. Today 16: 294-297, 1995
8. ZHANG, Y. & R. KOLESNICK: Signaling through the sphingomyelin pathway. Endocrinology 136: 4157-4160, 1995
9. LAULEDERKIND, S. J. F.; A. BIELAWSKA, R. RAGHOW, Y. A. HANNUN & L. R. BALLOU: Ceramide induces interleukin 6 gene expression in human fibroblasts. J. Exp. Med. 182: 599-604, 1995
10. 2 and cyclooxygenase 2. Biochem. Biophys. Res. Commun. 220: 681-686, 1996
11. KIRTIKARA, K.; S. J. F. LAULEDERKIND, R. RAGHOW, T. KANEKURA & L. R. BALLOU: An accessory role for ceramide in interleukin-1β induced prostaglandin synthesis. Mol. Cellular Biochem. 181: 41-48, 1998
12. BOLAND, M. P. & L. A. J. O'NEILL: Ceramide activates NF-κB by inducing the processing of p105. J. Biol. Chem. 273: 15494-15500, 1998
13. 3-induced HL-60 cell differentiation. J. Biol. Chem. 269: 4070-4077, 1994
14. WU, X.; H. LU, L. ZHOU & H. CHEN: Changes of phosphatidylcholine-specific phospholipase C in hepatocarcinogenesis and in the proliferation and differentiation of rat liver cancer cells. Cell Biol. Int. 21: 375-381, 1997
15. PANAGIA, V.; C. OU, Y. TAIRA, J. DAI & N. S. DHALLA: Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochim. Biophys. Acta 1064: 242-250, 1991
16. MASON, R. W.; G. D. GREEN & A. J. BARRETT: Human liver cathepsin L. Biochem. J 226: 233-241, 1985
17. THORNBERRY, N. A.; H. G. BULL, J. R. CALAYCAY, K. T. CHAPMAN, A. D. HOWARD, M. J. KOSTURA, D. K. MILLER, S. M. MOLINEAU, J. R. WEIDNER, J. AUNINS, et al.: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768-774, 1992
18. BARRETT, A. J. & H. KIRSCHKE: Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 80: 535-561, 1981
19. HOWARD, A. D.; M. J. KOSTURA, N. THORNBERRY, G. J. DING, G. LIMJUCO, J. WEIDNER, J. P. SALLEY, K. A. HOGQUIST, D. D. CHAPLIN, R. A. MUMFORD, et al.: IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J. Immunol. 147: 2964-2969, 1991